K2 Principal Fund’s MGC Diagnostics Corporation MGCD Stock Holding History
Bought
Maintained
Sold
K2 Principal Fund's MGCD Position: Q1 2018 in Review
K2 Principal Fund sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 52,416 shares — an estimated $578K sold.
K2 Principal Fund first reported a position in MGCD in Q4 2017 and held it in 1 quarter. The position peaked at $578K in Q4 2017. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.
- K2 Principal Fund reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
- K2 Principal Fund sold 52,416 MGC Diagnostics Corporation shares in Q1 2018, an estimated $578K.
- K2 Principal Fund first reported a position in MGC Diagnostics Corporation in Q4 2017 and held it in 1 quarter.
- K2 Principal Fund's MGC Diagnostics Corporation position peaked at $578K in Q4 2017.
- 0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.
Based on K2 Principal Fund's 13F filing for Q1 2018, filed 14 May 2018.